Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DIST_0727_s41591-020-0986-1

Exon skipping therapy for Batten disease

Aug 28, 2020 | 8:04 PM GMT

DISEASE CATEGORY: Neurology

INDICATION: Neurology

Antisense oligonucleotides that induce exon skipping in

Read the full 214 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE